IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Tejnaksh Healthcare IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 2.43 Cr. The company is based in Nashik and caters to Healthcare - Hospitals And Clinic sector. First Overseas Capital is the merchant banker of Tejnaksh Healthcare IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 18th September 2015.
Tejnaksh Healthcare IPO posted revenues of ₹ 2.05 crores and PAT of ₹ 0.60 crores in FY25 on annualised basis.
Revenue:
₹ 2.01 Cr.
EBITDA Margin:
50.25
% 
Net Worth: ₹ 2.49 Cr.
Market Capitalisation:
[●]
P/E:
14.00 times
P/BV: [●]
EV/EBITDA: 0.22 times
Financial results of Tejnaksh Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY15 | FY14 | FY13 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 3.53 | 2.98 | 2.01 | ||
| Net Worth | 2.49 | 1.89 | 1.32 | ||
| Total Debt | 0.43 | 0.47 | 0.36 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
2.01 | 1.44 | 1.14 | ||
EBITDA
EBITDA on annualised basis |
1.01 | 0.96 | 0.63 | ||
PAT
PAT on annualised basis |
0.60 | 0.57 | 0.31 | ||
Tejnaksh Healthcare IPO PAT Margin is 29.85 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Tejnaksh Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY15 | FY14 | FY13 |
|---|---|---|---|
| EBITDA Margin (%) | 50.25 | 66.67 | 55.26 |
| PAT Margin (%) | 29.85 | 39.58 | 27.19 |
| EPS (₹) | 7.47 | 7.15 | 3.90 |
| ROE (%) | 24.10 | 30.16 | 23.48 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 17.00 | 19.13 | 15.42 |
| Debt to Equity | 0.17 | 0.25 | 0.27 |
The market Capitalisation of Tejnaksh Healthcare IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Tejnaksh Healthcare IPO prospectus highlights an Return on Equity (ROE) of 24.10 % , Return on Assets (ROA) of 17.00 %, and an EBITDA Margin of 50.25 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Tejnaksh Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Tejnaksh Healthcare IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Tejnaksh Healthcare IPO has a Price-to-Earnings (PE) ratio of 14.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Tejnaksh Healthcare IPO reported revenue of ₹ 2.05 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Tejnaksh Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Tejnaksh Healthcare recorded an EBITDA of ₹ 1.01 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Tejnaksh Healthcare Profit After Tax (PAT) is ₹ 0.60 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 2.01 Cr.
EBITDA Margin:
50.25
%
Net Worth: ₹ 2.49 Cr.
Market Capitalisation:
[●]
P/E:
14.00 times
P/BV: [●]
EV/EBITDA: 0.22 times
Tejnaksh Healthcare operates in Healthcare - Hospitals And Clinic and Level Urology Hospital Located In The Heart Of Dhule City Maharashtra India. The Issue is listed on BSE SME in Oct, 2015. Tejnaksh Healthcare IPO size was 2.43 with Issue price of 80.00 .
Merchant Banker(s) of Tejnaksh Healthcare IPO: First Overseas Capital Limited
Tejnaksh Healthcare IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Tejnaksh Healthcare IPO listed at a listing price of 76.00 against the offer price of 80.00.
The current market price of Tejnaksh Healthcare is 19.29.
Why Us?
